Home > News > Foreword: touchREVIEWS in Ophthalmology
Cataract Surgery, Refractive Surgery
Read Time: 4 mins

Foreword: touchREVIEWS in Ophthalmology

Published Online: July 16th 2021
Quick Links:
Article
Article Information
Article:
Welcome to the first issue of touchREVIEWS in Ophthalmology, our new international ophthalmology journal, which replaces both the previous ophthalmology titles, European Ophthalmic Review and US Ophthalmic Review. The decision to merge the journals has been taken after a great year for touchOPHTHALMOLOGY, and we feel that in an increasingly global research community, submissions were being limited by an assumed primary reach to one regional audience. Merging the journals will allow us to grow the journal, while reflecting the new international audience in the change of title. The issue begins with two editorials on the subject of cataract surgery. First, Jonathan A Go et al. share five surgical pearls for optimizing outcomes of cataract surgery with patients with long eyes, which present unique challenges for cataract surgeons. In addition, Aman Mittal and Sumit Garg discuss the latest innovations in lens technology, including extended depth of focus, trifocal, innovative combination optics and modular intraocular lenses. The COVID-19 pandemic has presented unique challenges to all medical disciplines, and ophthalmology is no exception. Vance M Thompson shares his experiences from his clinic in terms of adapting to the pandemic and its impact on the healthcare landscape, while delivering the best possible visual outcomes to patients.

Next, in a commentary by Jesse Pelletier, he discusses the role of bacterial biofilms in the development of ocular surface disease, as well as novel therapeutic strategies that aim to eliminate them. Following this, we feature a number of review articles. Alessandro Marchese and Francesco Bandello review the current unmet needs in the postoperative management of cataract surgery, and discuss the latest advances in preventing infections and inflammation after cataract surgery. Our attention shifts next to the subject of diabetic retinopathy, which represents a major public health concern, given the global rise in incidence of diabetes. Abhinav R Bheemidi et al. review the clinical data in support of the use of aflibercept, the most recently developed and approved anti-vascular endothelial growth factor (VEGF) agent in the treatment of diabetic retinopathy.

Neovascular age-related macular degeneration is another major cause of visual loss whose outcomes have improved following the advent of
anti-VEGF therapy. However, some patients respond inadequately to anti-VEGF agents, and the need for frequent intravitreal injections can be a burden on patients and healthcare systems. Aamir A Aziz et al. review the efficacy and safety of faricimab, a bispecific antibody that binds both VEGF and angiopoietin-2, which is also upregulated in retinal vascular diseases.

Proptosis, an abnormal prominence of the eyeball beyond the confines of the bony orbit, is a sight-threatening disorder that can be a manifestation of serious disease. Syed Shoeb Ahmad et al. provide a comprehensive review of the causes, classification and management of proptosis, as well as providing an overview of thyroid eye disease, the most common cause of proptosis in everyday clinical practice.

The effect of cannabis on glaucoma has been debated for many years. In an original research article, Sameh Mosaed et al. present the findings of a randomized controlled clinical trial investigating the effect of inhaled cannabis on intraocular pressure in healthy adult subjects.

We end with a case report in which Spencer C Cleland et al. report a rare case of trichofolliculoma of the palpebral conjunctiva, which was successfully treated by complete surgical excision. touchREVIEWS in Ophthalmology would like to thank all expert authors who gave their time and effort to produce these insightful articles. We are also grateful to all organizations and society partners for their ongoing support, as well as our Editorial Board for their continued involvement and advice. The website (www.touchophthalmology.com/) features a wealth of expert content and we invite you too look through our archives. We hope that you will find this edition of touchREVIEWS in Ophthalmology an enjoyable and informative read.

Elizabeth Yeu, MD
Dr Yeu earned her medical degree through an accelerated and combined undergraduate/medical school programme at the University of Florida College of Medicine. She completed her ophthalmology residency at Rush University Medical Center in Chicago, where she served as Chief Resident (2006–2007). Dr Yeu continued to the Cullen Eye Institute, Baylor College of Medicine, to complete a fellowship in cornea, anterior segment and refractive surgery (2007–2008), where she served as an Assistant Professor after her fellowship training. Dr Yeu joined Virginia Eye Consultants in 2013, is now a partner (since 2014), and also continues her commitment to residency training in ophthalmology as an Assistant Professor at the Eastern Virginia Medical School. She is the Medical Director of CVP Physicians Mid-Atlantic and the Virginia Surgery Center, and also sits on the Board of Directors for the Virginia Eye Foundation. Dr Yeu provides guidance and governance across several national medical boards and committees, including as an examiner for the American Board of Ophthalmology, Secretary of the Executive Board of the American Society of Cataract and Refractive Surgery (ASCRS), the Chair of the Cataract Section of Ophthalmic News & Education (ONE) Network for the American Academy of Ophthalmology (AAO), and the Chair of the AAO Annual Meeting Refractive Surgery Sub-committee. Dr Yeu has authored numerous articles and is a frequent lecturer, nationally and internationally, in the areas of refractive cataract surgery, anterior segment reconstruction, ocular surface disease management, and surgical management of astigmatism. She is the Editor-in-Chief of touchREVIEWS in Ophthalmology and served as Medical Editor of the digital journal, Millennial Eye from 2015–2017. Dr Yeu has been voted onto The Opthalmologist’s global Power List four times: in 2015, 2017, 2019, and 2020. She was awarded the first Clinical Rising Star by the Ophthalmic Innovations Summit (OIS) in 2018, recognized as a Castle Connelly Top Doc 2016–2021 and received their Exceptional Women in Medicine Award in 2017–2018, earned the Best Doctors Award by her peers from 2013–2016, awarded the Millennial Eye Award in 2015, and recognized as one of the Top 40 Under 40 by Virginia’s Inside Business journal.

Article Information:

Further Resources

Share this Article
Related Content In Refractive Surgery
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72